2nd treatment for EGFR+ NSCLC with exon 19 deletions or exon 21 L858R mutations
RYBREVANT® + chemotherapy work together to target and fight cancer
RYBREVANT® is a targeted antibody* that works against EGFR in 2 main ways:
Works with your body's immune system to help destroy the cancer
RYBREVANT® is not chemotherapy, but works with it
- Chemotherapy is a key part of the treatment that stops cancer cells from dividing and growing
- RYBREVANT® and chemotherapy are effective together because they destroy cancer cells in different ways
Chemotherapy = carboplatin + pemetrexed
*Antibodies are protective proteins that help detect harmful substances and diseases such as cancers. They are made naturally by your immune system and can also be man-made. Man-made antibodies used to treat cancer have a specific target on a cancer cell that they aim to find, attach to, and attack. RYBREVANT® is a man-made antibody.
Side effects
There are side effects that you may experience during treatment with RYBREVANT®.
Savings & Support
Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.
The support and resources provided by RYBREVANT withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.
EGFR = epidermal growth factor receptor; NSCLC = non–small cell lung cancer